A-Alpha Bio launches a first-of-its-kind data consortium — with GSK among five founding members — to feed the AI models designing antibodies.
Biopharma’s AI engines need more data. And David Younger thinks there’s a great business to sell those data to them.
Younger’s startup, A-Alpha Bio, has …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Bristol Myers to build ‘powerful’ AI factory; Samsung Biologics bids for peptide maker
How AI is supercharging drug development
Biointron Launches RushData, an Integrated Platform for AI-Driven Antibody Discovery with 1-Day CHO Expression
Fierce Pharma Asia—GSK, Merck ADCs’ trial wins; AZ’s $1.5B EGFR buy; Biotechs’ new patent tricks
